Type of security: Stock
Sector: Consumer Services
Industry: Professional Services
Market Capitalization: 5.72 B
The data is delayed by 15 minutes.
Description: Genpact Limited provides business process management and information technology services worldwide. It offers finance and accounting services, including accounts payable services, payment and inquiry management, order to cash services, preparation of financial statements, closing and reporting, cash management, treasury, cash flow analysis, tax return preparation, financial planning and analysis, governance, and internal controls services. The company also provides smart decision services, such analytics and research; business consulting and enterprise risk consulting services comprising internal audit, compliance advisory, regulatory advisory, enterprise, IT, and fraud risk management services; and re-engineering services. In addition, it offers supply chain and procurement services consisting of direct and indirect sourcing and procurement, demand forecasting and management, engineering, inventory optimization and planning, fleet and logistics, and aftermarket services. Further, the company provides enterpr
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||210.52 M||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||-14.68%||Sales Growth - 4 Quarters||4.55%||Sales Growth - Q/Q||-2.39%||P/E|
|P/E To EPS Growth||P/S||2.44||P/BV||4.27||Price/Cash Per Share|
|Price/Free Cash Flow||27.31||ROA||6.8%||ROE||13.9%||ROI||8.59%|
|Current Ratio||2.09||Quick Ratio||Long Term Debt/Equity||1.06||Debt Ratio||0.42|
|Gross Margin||39.65%||Operating Margin||12.44%||Net Profit Margin||7.96%||Dividend Payout Ratio|
|Cash From Financing Activities||-15.79 M||Cash From Investing Activities||-31.79 M||Cash From Operating Activities||24.29 M||Gross Profit||229.68 M|
|Net Profit||44.65 M||Operating Profit||74.05 M||Total Assets||2.74 B||Total Current Assets||1.18 B|
|Total Current Liabilities||564.72 M||Total Debt||791.5 M||Total Liabilities||1.4 B||Total Revenue||587.15 M|
|High 52 week||41.83||Low 52 week||25.81||Last close||40.82||Last change||-1.04%|
|RSI||64.25||Average true range||0.78||Beta||0.73||Volume||333.5 K|
|Simple moving average 20 days||2.81%||Simple moving average 50 days||4.41%||Simple moving average 200 days||9.35%|
|Performance Week||2.77%||Performance Month||7.9%||Performance Quart||0.83%||Performance Half||13.89%|
|Performance Year||39.26%||Performance Year-to-date||51.63%||Volatility daily||1.04%||Volatility weekly||2.33%|
|Volatility monthly||4.77%||Volatility yearly||16.54%||Relative Volume||317%||Average Volume||1.03 M|
|New High||New Low|
2020-06-04 15:54:50 | Is Genpact Limited G Going to Burn These Hedge Funds?
2020-05-27 11:26:39 | Genpact G Will Emerge Stronger From the COVID-19 Crisis
2020-05-25 10:56:14 | Employers rethink talent and recruiting amid coronavirus
2020-05-21 13:31:11 | COVID 19 aftermath: Companies debate return-to-work, work-from-home policies
2020-05-21 10:43:21 | COVID-19 is accelerating our transition to a digital economy: Genpact CEO
2020-05-20 16:05:00 | Brian Stevens Appointed to Genpact's Board of Directors; James Madden Becomes Chairman
2020-05-20 16:01:00 | Genpact Limited Board Declares Quarterly Cash Dividend
2020-05-14 07:50:11 | Genpact G Beats Q1 Earnings Estimate Amid Coronavirus Crisis
2020-05-13 05:31:15 | Genpact G Q1 2020 Earnings Call Transcript
2020-05-12 09:31:10 | Edited Transcript of G earnings conference call or presentation 11-May-20 8:30pm GMT
2020-05-11 17:35:09 | Genpact G Beats Q1 Earnings and Revenue Estimates
2020-05-11 16:01:00 | Genpact Reports First Quarter 2020 Results
2020-05-08 14:45:00 | Genpact to Participate in Upcoming Investor Conference
2020-05-05 07:36:30 | What Is Genpact's NYSE:G P/E Ratio After Its Share Price Rocketed?
2020-05-01 11:40:03 | ATTO or G: Which Is the Better Value Stock Right Now?
2020-04-27 07:56:33 | When Should You Buy Genpact Limited NYSE:G?
2020-04-22 10:05:50 | J.P. Morgan Picks 2 Stocks to Buy and 1 to Sell
2020-04-16 09:00:00 | Genpact Schedules Earnings Release and Conference Call for First Quarter 2020 Results
2020-04-09 07:41:01 | Do Genpact's NYSE:G Earnings Warrant Your Attention?
2020-04-08 10:53:02 | Here's Why Investors Should Hold on to MAXIMUS MMS Stock
2020-04-07 21:32:01 | Here's Why You Should Hold on to Rollins ROL Stock Now
2020-04-01 08:15:12 | US Ecology Strengthens Cash Position Amid Coronavirus Crisis
2020-03-31 21:24:34 | SoftBank names Goldman alumnus Taiichi Hoshino head of investment planning dept
2020-03-31 08:15:00 | Everest Group Names Genpact a Leader in Supply Chain Management
2020-03-31 07:53:11 | Envestnet Picks CEO, President, Board Chairman & Vice Chairman
2020-03-27 09:43:01 | Rollins ROL Raises Paid Time Off Amid Coronavirus Outbreak
2020-03-25 10:50:02 | Here's Why You Should Invest in Omnicom OMC Stock Now
2020-03-25 08:27:12 | Aptiv APTV Reinforces Cash Position Amid Coronavirus Crisis
2020-03-25 08:23:12 | iClick ICLK to Report Q4 Earnings: What's in the Offing?
2020-03-22 23:58:06 | Hedge Funds Started Selling Genpact Limited G Before The Coronavirus
2020-03-20 10:15:02 | Charles River CRAI Appoints New Chief Financial Officer
2020-03-20 09:43:01 | Fiserv Snaps Up Bypass Mobile to Boost Omni-commerce Presence
2020-03-20 09:28:01 | FactSet FDS to Report Q2 Earnings: What's in the Offing?
2020-03-20 07:03:28 | With A Return On Equity Of 18%, Has Genpact Limited's NYSE:G Management Done Well?
2020-03-20 06:51:49 | How Does Genpact's NYSE:G P/E Compare To Its Industry, After The Share Price Drop?
2020-03-19 09:45:01 | IHS Markit INFO to Post Q1 Earnings: What's in Store?
2020-03-13 09:56:01 | What's in the Cards for GDS Holdings' GDS Q4 Earnings?
2020-03-13 09:11:01 | Here's Why You Should Invest in Charles River CRAI Now
2020-03-13 02:48:00 | Great Full-Year 2019 Numbers From Generali; Equally Great Buying Opportunity
2020-03-11 10:07:02 | Here's Why You Should Hold Automatic Data Processing Stock
2020-03-11 09:52:01 | PFSweb PFSW to Report Q4 Earnings: What's in the Offing?
2020-03-09 11:57:46 | Coronavirus outbreak causes ‘significant deterioration’ of PerkinElmer sales